Key model for drug development of primary biliary cholangitis
Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is an organ-specific, chronic cholestatic autoimmune liver disease. The disease is notably characterized by intrahepatic cholestasis, the presence of antimitochondrial antibodies in the circulating blood, and progressive, non-suppurative inflammatory destruction of the small intrahepatic bile ducts, which ultimately leads to extensive hepatic ductal destruction, biliary cirrhosis, and even liver failure.
We have established a stable model of bile duct ligation-induced primary biliary cholangitis and a model of α-naphthyl isothiocyanate (ANIT)-induced primary biliary cholangitis, which are suitable for the study of drugs for preclinical primary biliary cholangitis and the evaluation of new drugs.
If you have project needs and experience more of our professional services, please contact us.
Our services
Model classification | Model Name | Animal species |
Primary biliary cholangitis | Model of primary biliary cholangitis induced by bile duct ligation | Mice,rats |
Model of primary biliary cholangitis induced by alpha-naphthyl isothiocyanate (ANIT) | Mice,rats |
Case sharing